Tag: Occupational Hazards

FDA revokes EUA for non-NIOSH-approved respirators

Editor's Note The Food and Drug Administration (FDA) on June 30 announced that it is revoking the Emergency Use Authorizations (EUAs) for non-NIOSH-approved disposable respirators (including N95s), effective July 6. The announcement also revokes EUAs for decontamination and bioburden reduction systems for disposable respirators, effective immediately. The FDA says the…

Read More

By: Judy Mathias
July 1, 2021
Share

COVID-19 hospitalization, mortality rates before, after reopening US economy

Editor's Note This study led by researchers at the department of economics, Indiana University-Purdue University, Indianapolis, finds that state policies implemented in spring 2020 to protect hospital capacity and minimize deaths due to COVID-19 were associated with upward trends in hospitalizations and mortality after reopening. The researchers examined data collected…

Read More

By: Judy Mathias
June 30, 2021
Share

Mental health of high school students during COVID-19 pandemic

Editor's Note This study from Austria finds a high prevalence of mental disorders in high school students 1 year after the COVID-19 pandemic began. Of 3,052 adolescents who participated in the study: 55% had clinically relevant depressive symptoms 47% had clinically relevant anxiety symptoms 22.8% had clinically relevant moderate insomnia…

Read More

By: Judy Mathias
June 29, 2021
Share

Growing number of hospitals, healthcare systems mandating COVID-19 vaccinations for HCWs

Editor's Note The number of hospitals and healthcare systems mandating COVID-19 vaccinations for their healthcare workers (HCWs) is growing, the June 29 Becker’s Hospital Review reports. In chronological order, the organizations that have announced mandates as of June 29 are: Henry Ford Health System, Detroit, will require its workforce of…

Read More

By: Judy Mathias
June 29, 2021
Share

CDC: More than half of public HCWs experienced mental health symptoms during COVID-19 pandemic

Editor's Note This survey of 26,174 public healthcare workers (HCWs) from March 29 to April 16, 2021, by researchers from the Centers for Disease Control and Prevention (CDC), finds that 53% had experienced at least one mental health condition in the previous 2 weeks. Prevalences of symptoms were: depression: 32%…

Read More

By: Judy Mathias
June 28, 2021
Share

Study: Surgical face masks protect against aerosols, plastic face shields provide no protection

Editor's Note Wearing a surgical face mask can provide similar protection against aerosols as wearing a respirator, but face shields provide little or no protection, finds this study, which will be presented at the European Congress of Clinical Microbiology & Infectious Diseases July 9-12. German researchers compared 32 types of…

Read More

By: Judy Mathias
June 24, 2021
Share

Effect of mask use on COVID-19 positivity rates in HCWs

Editor's Note This study led by researchers with the Southern California Permanente Medical Group, Pasadena, found no association in COVID-19 positivity rates among healthcare workers (HCWs) wearing respirator masks vs medical masks when performing nonaerosolizing, routine patient care. Of 1,414 HCWs involved in the study: 595 (42.1%) had exposures to…

Read More

By: Judy Mathias
June 24, 2021
Share

COVID-19 antibodies found in blood donated by Americans in December 2019

Editor's Note COVID-19 virus antibodies were detected in 106 specimens from American Red Cross blood donations in California, Oregon, and Washington, as early as December 13-16, 2019, finds this study by researchers from the Centers for Disease Control and Prevention and American Red Cross. Similarly, antibodies were identified in blood…

Read More

By: Judy Mathias
June 23, 2021
Share

CDC: More than 150M Americans fully vaccinated

Editor's Note As of Monday, June 22, 150,424,675 Americans had been fully vaccinated against COVID-19 (45.3% of the population), and 177,635,067 had received at least one dose (53.5% of the population), the Centers for Disease Control and Prevention (CDC) reports. This tally includes two doses of the Moderna or Pfizer…

Read More

By: Judy Mathias
June 23, 2021
Share

Use of ivermectin for prevention, treatment of COVID-19

Editor's Note This systematic review, meta-analysis, and trial sequential analysis by UK researchers find that the FDA-approved, anti-parasitic drug ivermectin could reduce COVID-19 related deaths and infections. The data showed: The use of ivermectin to treat patients with mild-to-moderate COVID-19 reduced risk of death by an average of 62%. The…

Read More

By: Judy Mathias
June 22, 2021
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat